What does it really take for a biotech company to become an attractive acquisition target?
In this episode of PharmaShots CXO Talks, Jared Kelly, CEO & Director of Oncolytics Biotech, shares an insider's perspective shaped by years of experience in biotech transactions, corporate strategy, and business development.
Before joining Oncolytics, Kelly served as Head of…
Shots
• HLTH Europe 2026 brought together over 5,000 healthcare leaders, investors, policymakers, payers, providers, pharmaceutical executives, and digital health innovators in Amsterdam to explore the future of healthcare innovation.
• Healthcare has a paradox: brilliant point solutions are failing not because they don't work, but because they can't talk to each other. A patient…
Shots:
HLTH Europe 2026 brought together healthcare leaders, innovators, and policymakers to explore the future of healthcare delivery, digital transformation, patient engagement, and value-based care. Among the key topics discussed was the growing role of GLP-1 therapies and how data-driven care models are reshaping chronic disease management.
Withings Health Solutions is helping advance this transformation through…
Shots:
This edition explores Digital Vigilance: AI Enhancing Post-Market Safety Monitoring, highlighting how artificial intelligence, real-world data, and digital listening technologies are transforming pharmacovigilance into a proactive, predictive, and patient-centric discipline.
Through expert perspectives, cover stories, and regulatory insights, we examine the opportunities and challenges of AI-driven safety surveillance—from social media signal detection and real-world…
Shots:
PharmaShots’ May Edition explores how AI is transforming commercial strategies across the healthcare ecosystem by enabling predictive analytics, personalized engagement, dynamic launch planning, and real-time omnichannel optimization while balancing compliance and measurable ROI.
The magazine highlights key industry movements shaping global biopharma, including AI-driven drug discovery collaborations, strategic M&A activity, advancements in cell and…
• The PharmaShots Awards 2026 – Market Titans & Innovators represents a global celebration of healthcare innovation, establishing a strong benchmark by recognizing excellence across biopharma, medtech, diagnostics, generics, nutraceuticals, animal health, digital health, and AI-driven drug discovery while bringing the entire ecosystem onto one unified stage.
• The awards honor industry leaders driving real…
Shots:
AI is redefining compliance from reactive to predictive, as this April edition highlights how AI-powered systems are transforming regulatory oversight into a continuous, real-time, and data-driven function, enabling early risk detection, automated audits, and smarter regulatory collaboration across the pharma value chain.
Strategic dealmaking and AI partnerships shape industry momentum, with March witnessing high-value…
Shots:
Dr. Emanuela Offidani explains how ADHD is increasingly recognized as a lifelong condition affecting both children and adults. She highlights that symptoms can differ across genders and are often underdiagnosed in women due to less visible hyperactivity and more internalized symptoms such as inattention and emotional dysregulation.
The conversation explores how Tris Pharma is…
Shots
AI is transforming clinical trial oversight from periodic monitoring to continuous, real-time intelligence, enabling early detection of safety signals, protocol deviations, and operational risks while strengthening data integrity and patient protection.
Advanced analytics and machine learning are powering predictive, risk-based monitoring, integrating data from decentralized trials, wearables, ePROs, and multiple clinical systems to prioritize…
Shots:
• From navigating six cancer diagnoses to building a mission-driven brand, Liz Benditt turned her personal journey into purpose by founding The Balm Box, a company designed to make treatment days a little less overwhelming and a lot more thoughtful for patients and caregivers alike.
• In this CXO Talks episode, we dive into…

